Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000755

Drug Information
NameReserpine
SynonymsRenese R; Reserlor; Serpanray; Rauserpin; Sedaraupina; T-Serp; Hypersil; Serpogen; Raupoid; Key-serpine; V-Serp; Cam-Ap-Es; V Serp; Reserjen; Hydropres 50; Diupres 500; HMS500A14; IDI1_000012; Raunervil; Seominal; 83580_FLUKA; Escaspere; VI XO; KBio2_000549; Neoserp; Serpine; Reserpidefe; Rauwilid; KBio1_000012; Respital; Hydromox R; Austrapine; Supergan; DB00206; Serpyrit; rau sedyl; Eskaserpine; Rauloydin; Carditivo; STK801975; H.R.-50; NCI-C50157; Adelphin; Kitine; Reserutin; VIXO; Serpoid; Diupres-500; loweser p; Carrserp; KBio2_005685; Roxynoid; Sertensin; Rausedyl; Roxel; 1407-38-1; Rausedan; Eserpine; Deserpine; Reserpamed; Tylandril; Maviserpin; Serpaloid; Serfin; Sertina; Raucap; l"-Carpserp; Hexaplin; Resine; Dralserp; Reserpka; R0875_SIGMA; BB_NC-1905; Residin; D012110; Darebon; ENT 50146; Lemiserp; Hydroserp; Regroton; Sandril; Rivasin; Hydrap-ES; SK-Reserpine; C06539; 3P Reserp; Resercen; Raudixoid; Raulen; CHEMBL772; Rivased; Hypercal B; Serpivite; Reserpur; 50-55-5; Hypersine; Sertabs; Rauvlid; Raugal; Triserpin; Veriloid; Benazyl; HMS1570P11; Temposerpine; R 0875; Resaltex; Rauserpine; CHEBI:28487; Rauwasedin; Hydromox-R; Hydrosine 25; Serpiloid; Pressimedin; Serpivate; Rauwoleaf; Rolserp; HMS1920P04; Eberpine; Diupres 250; reserpine; Reserbal; Serpaneurona; Diupres-250; Reserpal; Rese-lar; Mallopress; Modenol; Hiserpia; Abesta; Ascoserpina; Sandron; Tepserpine; D00197; l -Carpserp; Raurine; Serpilum; Gilucard; Diurese-R; KBio3_001808; Resocalm; Hydropres 25; esc aspere; Terbolan; Resedril; Loweserp; Raupasil; EU-0100073; NSC 237659; BRN 0102014; Sedserp; Hydropine; Naquival; Sertens; Recipin; Banisil; Serpen; Resedrex; NSC59272; nembuserpin; Rautrin; Apoplon (TN); Bioserpine; Reserp; Reserpinum; Hiposerpil; Unipres; Sedaraupin; Purserpine; Rauwiloid; gammaserpine; Tensionorme; Rausedil; Tenserpinie; NINDS_000012; Serpate; Serpedin; Tensional; Rauwita; Eskaserp; Sederaupin; Helfoserpin; Mayserpine; Brinderdin; Reserpin; :reserpine; HYDRO-RESERP; AI3-50146; NSC237659; neose rfin; Adelfan; Ryser; Rausan; SPBio_002870; Serpone; Rauserpol; NCI60_004446; Elfanex; Ser-A-Gen; Resercaps; Broserpine; Idoserp; Serpipur; Reserpoid; Ebserpine; Serolfia; LS-1306; Abicol; Reserpanca; Rauwipur; se rpate; R-e-s; Cardioserpin; Serpil; Serpentil; Serpalan; Serpazil; Raumorine; Usaf cb-27; Serpentin; Serpena; Enipresser; Banasil; Rawilid; Serpentina; Orthoserpina; Klimanosid; Residine; H 520; Neoslowten; Resperin; Raunova; Briserine; Serpasil; Serpazol; Reserpil; Diutensen-R; Reserpina; Tefaserpina; Rezerpin; Resperine; Hypertensan; Alkaserp; HMS2092G05; 8048-25-7; Neoserfin; Serpasol; Unilord; Perskleran; Ascoserp; ACon1_000086; Alkarau; Apsical; Reser-ar; Serfolia; Reserpex; Raudixin; AC1L1L3K; Interpina; Rau-Sed; AC-13142; Idsoserp; Carpacil; Transerpin; Quiescin; Resiatric; CCRIS 550; 141099-49-2; Salupres; HSDB 213; MLS002154046; Elserpine; Raunorine; Rausingle; Renese-R; Tensanyl; KBio2_003117; Eberspine; Reserfia; Riserpa; Mephaserpin; CID5770; Restran; Apoplon; rese rpamed; Vio-Serpine; Alserin; Roxinoid; neo-serp; Raudiford; SMR000059122; Reserpene; Serpicon
IndicationHypertension
[ICD9: 401   ICD10: I10, I11, I12, I13, I15]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-
11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-2
4(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-1
0,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1
InChIKeyQEVHRUUCFGRFIF-MDEJGZGSSA-N
Canonical SMILESCOC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=
C6)OC)OC)OC    
Isomeric SMILESCO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC
(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC
Therapeutic ClassAntihypertensive Agents
CAS NumberCAS 50-55-5
FormulaC33H40N2O9
PubChem Compound IDCID 5770.
PubChem Substance IDSID 8769.
ChEBI28487;
SuperDrug ATC IDC02AA02
SuperDrug CAS ID000050555;
TargetSynaptic vesicle amine transporterBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 009838 To Reference
Ref 2Dopamine signaling is required for depolarization-induced slow current in cerebellar Purkinje cells. J Neurosci. 2009 Jul 1;29(26):8530-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543